Lindsay Kathleen Hill1,2, Stewart Russell3,4, Dung Minh Hoang1, and Youssef Zaim Wadghiri1
1Radiology, NYU School of Medicine, New York, NY, United States, 2Biomedical Engineering, SUNY Downstate Medical Center, Brooklyn, NY, United States, 3Thayer School of Engineering, Dartmouth College, Hanover, NH, United States, 4Department of Mechanical Engineering, The City College of New York, New York, NY, United States
Synopsis
Advancement in the field of Gadolinium-bound contrast agent
discovery is reliant on the development and characterization of novel
constructs made in-house. However, the assessment of physicochemical
properties and in
vivo pharmacokinetics,
requiring highly sensitive measurements, is often impeded by the lack of
analytical techniques that are simultaneously sensitive, affordable, and
accessible. Here we demonstrate that Carbostyril 124-sensitized DTPA can be incorporated into a lipid-based microparticle, allowing for rapid
quantification of Gadolinium concentration with nanomolar sensitivity using a
readily available fluorescence plate reader. This sensitive and convenient
technique could rapidly propel the characterization of novel MR contrast agents. Purpose
Gadolinium (Gd)-based paramagnetic contrast agents,
including Gd-bound micelles and liposomes, are increasingly used preclinically in
MR for diagnostic studies. Advancement in this field relies on the in-house engineering
of new constructs. Critical to this development is the characterization of physicochemical
properties and
in vivo pharmacokinetics, requiring highly sensitive Gd
concentration measurements. Inductively coupled plasma mass spectrometry (ICP-MS)
is the highly sensitive gold standard, but it is expensive and requires
specialized equipment
1. NMR relaxometry is more affordable, but requires a
large sample volume due to limited sensitivity
2. We previously demonstrated
an alternative strategy using a Carbostyril 124 (cs124)-sensitized
DTPA to quantify Gd agents at the nanomolar levels
3 with a fluorescence plate
reader widely available in research labs. Here we show that cs124-sensitized
DTPA can be extended to multi-Gd based agents, as demonstrated in a lipid-based microparticle. As
these agents are increasingly investigated for MR angiography and molecular
imaging due to the amplification effect of multiple Gd ions on contrast
enhancement, the need to quickly and accurately characterize their
concentration and clearance kinetics is critical.
Background
Here the cs124-sensitized DTPA lipid
construct, cs124-GdDTPA-1,2-dipalmitoyl-
sn-glycero-3-phosphoethanolamine
(cs124-GdDTPA-DPPE), shown in Fig. 1(A), is the energy donor and unsensitized Terbium-DTPA
(TbDTPA) is the acceptor. Excitation of cs124-Gd does not result in
fluorescence emission, but instead creates a long-lived excited electron
energetic state that is transferred to Tb by collision. Because Tb is not
fluorescent without a sensitizer, time-resolved detection of Tb’s
characteristic fluorescence spectrum is proportional to the concentration of
sensitized Gd.
Methods
The
construct cs124-DTPA-DPPE
was sonicated in deionized water and chelation of Gd was performed in deionized
water for 1hour at 90°C (10:1
GdCl3:cs124-DTPA-DPPE). Unchelated Gd was separated from
the construct through a 3kDa filter. Dynamic light scattering (DLS) was used to determine
the size distribution of the filtered product. TbDTPA was generated by combining TbCl3 and
DTPA 1:1 in deionized
water for 1hour at 90°C.
Determination of Gd
concentration
Absorbance
measurements were made for cs124-GdDTPA-DPPE, and then for DTPA alone, which
was subtracted from the raw signal to normalize the cs124 signal of the lipid-based
particle. The concentration of cs124 was determined to be C=A ε-1 L-1, where A is
absorbance, L=1cm, and ε was taken
to be the same as that of cs124-DTPA alone, 1.07x104 M-1cm-1,
as previously described3. Based on the construct design, the concentration
of Gd is equal to that of cs124.
Fluorescence Assay
cs124-GdDTPA-DPPE
particles were plated in triplicate in a black 96-well plate at concentrations
ranging from 35μM to 10-10M in 100μl deionized water, followed by 10μl of 1nM TbDTPA per well. The plate was excited
at 330nm and emission at 480nm was integrated from 600μs to 2000μs. The collision
model of energy transfer3 was
fit to fluorescence, showing that the energy
transfer characteristics from these particles to Tb are the same as for
molecular cs124-GdDTPA.
MRI
2D T1
and T2 maps were obtained on a 7-Tesla Bruker system. Phantoms were created
using clinical Gd-DTPA (Magnevist) and cs124-GdDTPA-DPPE particles diluted in
HEPES physiological buffer, pH 7, to concentrations of 5μM-0.5mM and
5μM-50μm, respectively. From the acquired relaxation times, T1 and T2, we
determined the relaxivities, r1 and r2, of Magnevist and our particles at 7T.
The ratio r2/r1 was calculated to demonstrate their effectiveness as T1 agents.
Results
DLS of Gd-chelated cs124-DTPA-DPPE revealed an average diameter
of 1.2μm (Fig. 1(B)), suggesting the formation of liposomes of the giant
unilamellar vesicle or multilamellar vesicle subtype4. The liposomes’
absorption spectrum revealed a maximum absorbance at 330nm, which was used to
calculate the concentration of Gd in our sample to be 35μM (Fig. 2). Time-resolved
fluorescence showed a detection limit of 10nM Gd (Fig. 3), which is comparable
to ICP-MS1.
Both a T1-weighted image as well as T1 and T2 maps of the
liposomes revealed profound T1-shortening as compared to Magnevist. The T1-weighted signal of 0.05mM Gd-liposomes, in red, was comparable to that of 10x
the Magnevist concentration, 0.5mM (Fig. 4). Liposome relaxivity r1 was 26.5x higher than that of Magnevist and the
liposomes’ r2/r1 of 1.04 shows promise for the sensitized lipid construct’s incorporation
into novel T1 agents (Table 1).
Conclusion
We show that cs124-GdDTPA-DPPE lipid can be incorporated
into mesoscale Gd-bound lipid-based particles, and can be used to quantify Gd
concentration by fluorescence. Notably,
all absorbance and fluorescence studies were conducted on a spectrophotometer equipped
for time resolved studies, which delivers rapid results and is found in most
laboratory settings. This expedient and sensitive system may significantly propel optimization studies of novel lipid-based MR contrast agents made in-house.
Acknowledgements
This work was supported in part by the NYU Applied
Research Support Fund and resource support from NIH/NCI 5P30CA016087-32 and NIH
P41 EB017183.References
[1] Telgmann L, et al. Identification and quantification of potential metabolites exposed to different gadolinium-based MRI contrast agents: evaluation with inductively coupled plasma mass spectrometry (ICP-MS). J Chromatogr A. 2012; 1240: 147-155.
[2] Bourasset F, et al. Comparison of plasma and peritoneal concentrations of various categories of MRI blood pool agents in a murine experimental pharmacokinetic model. MAGMA. 2001; 12(2-3): 82-87.
[3] Russell S, et al. Quantification of the plasma clearance kinetics of a gadolinium-based contrast agent by photoinduced triplet harvesting. Anal Chem. 2012; 84(19): 8106-8109.
[4] Torchilin VP, et al. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov. 2005; 4(2):
145-160.